S&P Biotech SPDR (XBI)
$112.89 0.42 (0.37%)
20:00 EDT XBI Stock Quote Delayed 30 Minutes
Previous Close $112.89
Market Cap 6.10B
PE Ratio -
Volume (Avg. Vol.) 5.05M
Day's Range 111.95 - 114.28
52-Week Range 62.94 - 115.77
Dividend & Yield 0.23 (0.20%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
- From InvestorPlace
- From the Web
The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.
By Ian Cooper
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
By Ian Cooper
Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.
Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.
HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.
SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.
As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
A phase of weakness has hit Wall Street, but the dip could be a buy. Here are three bullish options trades to consider in V, BIDU and XBI.
Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
By Jeff Reeves
The best healthcare ETFs for 2018 offer growth and stability. These funds show healthcare investing is both low risk and high reward.
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
From Talk Markets